Evidence map›Paper›PMID 38711218›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Single-Cell Transcriptome Landscape and Cell Fate Decoding in Human Brain Organoids after Transplantation.

Shi-Bo Xu, Xin-Rui Li, Pan Fan, Xiyang Li, Yuan Hong, Xiao Han, Shanshan Wu, Chu Chu, Yuejun Chen, Min Xu and 3 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shi-Bo XuState Key Laboratory of Reproductive Medicine, Institute for Stem Cell and Neural Regeneration, School of Pharmacy, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, 211166, P. R. China.
Xin-Rui LiState Key Laboratory of Reproductive Medicine, Institute for Stem Cell and Neural Regeneration, School of Pharmacy, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, 211166, P. R. China.
Pan FanState Key Laboratory of Reproductive Medicine, Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, 211166, P. R. China.
Xiyang LiState Key Laboratory of Reproductive Medicine, Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, 211166, P. R. China.
Yuan HongState Key Laboratory of Reproductive Medicine, Institute for Stem Cell and Neural Regeneration, School of Pharmacy, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, 211166, P. R. China.
Xiao HanState Key Laboratory of Reproductive Medicine, Institute for Stem Cell and Neural Regeneration, School of Pharmacy, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, 211166, P. R. China.
Shanshan WuState Key Laboratory of Reproductive Medicine, Institute for Stem Cell and Neural Regeneration, School of Pharmacy, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, 211166, P. R. China.
Chu ChuState Key Laboratory of Reproductive Medicine, Institute for Stem Cell and Neural Regeneration, School of Pharmacy, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, 211166, P. R. China.
Yuejun ChenInstitute of Neuroscience, Key Laboratory of Primate Neurobiology, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, 200031, China.
Min XuState Key Laboratory of Reproductive Medicine, Institute for Stem Cell and Neural Regeneration, School of Pharmacy, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, 211166, P. R. China.
Mingyan LinState Key Laboratory of Reproductive Medicine, Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, 211166, P. R. China.
Xing GuoState Key Laboratory of Reproductive Medicine, Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, 211166, P. R. China.
Yan LiuState Key Laboratory of Reproductive Medicine, Institute for Stem Cell and Neural Regeneration, School of Pharmacy, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, 211166, P. R. China.ORCID 0000-0003-2918-5398

Funding

National Key Research and Development Program of China 2019YFA0802700National Key Research and Development Program of China 2019YFA0802703National Key Research and Development Program of China 2021YFA1101800National Key Research and Development Program of China 2021YFA1101802National Key Research and Development Program of China 2022YFA1104800National Key Research and Development Program of China 2023YFF1203600National Natural Science Foundation of China 22274079National Natural Science Foundation of China 82171528National Natural Science Foundation of China 82325015National Natural Science Foundation of China 82371260National Natural Science Foundation of China U23A20429
6 · The paper itself

Abstract

Human stem cells and derivatives transplantation are widely used to treat nervous system diseases, while the fate determination of transplanted cells is not well elucidated. To explore cell fate changes of human brain organoids before and after transplantation, human brain organoids are transplanted into prefrontal cortex (PFC) and hippocampus (HIP), respectively. Single-cell sequencing is then performed. According to time-series sample comparison, transplanted cells mainly undergo neural development at 2 months post-transplantation (MPT) and then glial development at 4MPT, respectively. A different brain region sample comparison shows that organoids grafted to PFC have obtained cell fate close to those of host cells in PFC, other than HIP, which may be regulated by the abundant expression of dopamine (DA) and acetylcholine (Ach) in PFC. Meanwhile, morphological complexity of human astrocyte grafts is greater in PFC than in HIP. DA and Ach both activate the calcium activity and increase morphological complexity of astrocytes in vitro. This study demonstrates that human brain organoids receive host niche factor regulation after transplantation, resulting in the alignment of grafted cell fate with implanted brain regions, which may contribute to a better understanding of cell transplantation and regenerative medicine.

Indexed as

OrganoidsTranscriptomeBrainCell DifferentiationHippocampusHumansPrefrontal CortexSingle-Cell Analysisastrocytehuman brain organoidsneurotransmittersingle‐cell RNA sequencingtransplantation therapy

Identifiers

PMID38711218
PMCPMC11267311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.